209 related articles for article (PubMed ID: 32893672)
1. Targeting FFA1 and FFA4 receptors in cancer-induced cachexia.
Freitas RDS; Muradás TC; Dagnino APA; Rost FL; Costa KM; Venturin GT; Greggio S; da Costa JC; Campos MM
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E877-E892. PubMed ID: 32893672
[TBL] [Abstract][Full Text] [Related]
2. Agonism of free fatty acid receptors 1 and 4 generates peptide YY-mediated inhibitory responses in mouse colon.
Moodaley R; Smith DM; Tough IR; Schindler M; Cox HM
Br J Pharmacol; 2017 Dec; 174(23):4508-4522. PubMed ID: 28971469
[TBL] [Abstract][Full Text] [Related]
3. Functional expression of the free fatty acids receptor-1 and -4 (FFA1/GPR40 and FFA4/GPR120) in bovine endometrial cells.
Valenzuela P; Teuber S; Manosalva C; Alarcón P; Figueroa CD; Ratto M; Burgos RA; Hidalgo MA
Vet Res Commun; 2019 Aug; 43(3):179-186. PubMed ID: 31187404
[TBL] [Abstract][Full Text] [Related]
4. Label-free cell phenotypic study of FFA4 and FFA1 and discovery of novel agonists of FFA4 from natural products.
Xu F; Zhou H; Liu X; Zhang X; Wang Z; Hou T; Wang J; Qu L; Zhang P; Piao H; Liang X
RSC Adv; 2019 May; 9(26):15073-15083. PubMed ID: 35516320
[TBL] [Abstract][Full Text] [Related]
5. Involvement of FFA1 and FFA4 in the regulation of cellular functions during tumor progression in colon cancer cells.
Takahashi K; Fukushima K; Onishi Y; Minami K; Otagaki S; Ishimoto K; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2018 Aug; 369(1):54-60. PubMed ID: 29750897
[TBL] [Abstract][Full Text] [Related]
6. In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469.
Urban C; Hamacher A; Partke HJ; Roden M; Schinner S; Christiansen E; Due-Hansen ME; Ulven T; Gohlke H; Kassack MU
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1021-30. PubMed ID: 23861168
[TBL] [Abstract][Full Text] [Related]
7. Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases.
Christiansen E; Watterson KR; Stocker CJ; Sokol E; Jenkins L; Simon K; Grundmann M; Petersen RK; Wargent ET; Hudson BD; Kostenis E; Ejsing CS; Cawthorne MA; Milligan G; Ulven T
Br J Nutr; 2015 Jun; 113(11):1677-88. PubMed ID: 25916176
[TBL] [Abstract][Full Text] [Related]
8. Long-Chain Fatty Acid Receptors Mediate Relaxation of the Porcine Lower Esophageal Sphincter.
Tsai CC; Li YC; Chang LC; Tey SL; Lin KJ; Huang SC
Front Physiol; 2019; 10():676. PubMed ID: 31214048
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid and TUG-891 activate free fatty acid-4 receptor in bovine neutrophils.
Olmo I; Teuber S; Larrazabal C; Alarcon P; Raipane F; Burgos RA; Hidalgo MA
Vet Immunol Immunopathol; 2019 Mar; 209():53-60. PubMed ID: 30885306
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.
Briscoe CP; Peat AJ; McKeown SC; Corbett DF; Goetz AS; Littleton TR; McCoy DC; Kenakin TP; Andrews JL; Ammala C; Fornwald JA; Ignar DM; Jenkinson S
Br J Pharmacol; 2006 Jul; 148(5):619-28. PubMed ID: 16702987
[TBL] [Abstract][Full Text] [Related]
11. Treatment with TUG891, a free fatty acid receptor 4 agonist, restores adipose tissue metabolic dysfunction following chronic sleep fragmentation in mice.
Gozal D; Qiao Z; Almendros I; Zheng J; Khalyfa A; Shimpukade B; Ulven T
Int J Obes (Lond); 2016 Jul; 40(7):1143-9. PubMed ID: 26980479
[TBL] [Abstract][Full Text] [Related]
12. Regulation of prohormone convertase 2 protein expression via GPR40/FFA1 in the hypothalamus.
Nakamoto K; Aizawa F; Nishinaka T; Tokuyama S
Eur J Pharmacol; 2015 Sep; 762():459-63. PubMed ID: 26071852
[TBL] [Abstract][Full Text] [Related]
13. The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system.
Nakamoto K; Nishinaka T; Sato N; Aizawa F; Yamashita T; Mankura M; Koyama Y; Kasuya F; Tokuyama S
Br J Pharmacol; 2015 Mar; 172(5):1250-62. PubMed ID: 25362997
[TBL] [Abstract][Full Text] [Related]
14. Improvement by eicosanoids in cancer cachexia induced by LLC-IL6 transplantation.
Ohira T; Nishio K; Ohe Y; Arioka H; Nishio M; Funayama Y; Ogasawara H; Fukuda M; Yazawa K; Kato H; Saijo N
J Cancer Res Clin Oncol; 1996; 122(12):711-5. PubMed ID: 8954167
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.
Liu Z; Hopkins MM; Zhang Z; Quisenberry CB; Fix LC; Galvan BM; Meier KE
J Pharmacol Exp Ther; 2015 Feb; 352(2):380-94. PubMed ID: 25491146
[TBL] [Abstract][Full Text] [Related]
16. Understanding the appetite modulation pathways: The role of the FFA1 and FFA4 receptors.
Freitas RDS; Campos MM
Biochem Pharmacol; 2021 Apr; 186():114503. PubMed ID: 33711286
[TBL] [Abstract][Full Text] [Related]
17. Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders.
Moniri NH
Biochem Pharmacol; 2016 Jun; 110-111():1-15. PubMed ID: 26827942
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism.
Hudson BD; Shimpukade B; Mackenzie AE; Butcher AJ; Pediani JD; Christiansen E; Heathcote H; Tobin AB; Ulven T; Milligan G
Mol Pharmacol; 2013 Nov; 84(5):710-25. PubMed ID: 23979972
[TBL] [Abstract][Full Text] [Related]
19. Agonism of GPR120 prevented IL-1β-induced reduction of extracellular matrix through SOX-9.
Xu Z; Ke T; Zhang Y; Fu C; He W
Aging (Albany NY); 2020 Jun; 12(12):12074-12085. PubMed ID: 32580167
[TBL] [Abstract][Full Text] [Related]
20. Fish oil attenuated dystrophic muscle markers of inflammation via FFA1 and FFA4 in the mdx mouse model of DMD.
Maciel Junior M; Camaçari de Carvalho S; Saenz Suarez PA; Santo Neto H; Marques MJ
Anat Rec (Hoboken); 2021 Jun; 304(6):1305-1312. PubMed ID: 33136305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
